ED
ALU

Exane Derivatives’s Alcatel-Lucent ALU Stock Holding History

Exane Derivatives’s Portfolio ALU Stock Details ALU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10
Closed -$391 – 587
2015
Q3 		$391 Sell
10
-1,140
-99% -$3.99K ﹤0.01% 453
2015
Q2 		$51.8K Buy
1,150
+840
+271% +$3.23K 0.01% 285
2015
Q1 		$5.84K Buy
+310
New +$1.14K ﹤0.01% 400

Other funds holding ALU

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BCM
BBT Capital Management Fort Worth, Texas $85.5M AUM 11.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Exane Derivatives's ALU Position: Q4 2015 in Review

Exane Derivatives sold out of Alcatel-Lucent (ALU) in Q4 2015, closing a stake of 429,779 shares — an estimated $1.57M sold.

Exane Derivatives first reported a position in ALU in Q4 2014 and held it in 4 quarters. The position peaked at $6.21M in Q4 2014. 232 funds tracked by Wall St. Rank hold ALU as of Q4 2015.

  • Exane Derivatives reported no remaining Alcatel-Lucent position as of Q4 2015 after selling out during the quarter.
  • Exane Derivatives sold 429,779 Alcatel-Lucent shares in Q4 2015, an estimated $1.57M.
  • Exane Derivatives first reported a position in Alcatel-Lucent in Q4 2014 and held it in 4 quarters.
  • Exane Derivatives's Alcatel-Lucent position peaked at $6.21M in Q4 2014.
  • 232 funds tracked by Wall St. Rank held Alcatel-Lucent as of Q4 2015.

Based on Exane Derivatives's 13F filing for Q4 2015, filed 11 Feb 2016.